{"name":"S-INFINITY Pharmaceuticals Co., Ltd","slug":"s-infinity-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOS1d5X2ZDZnQ4dUxnSGdKN0lWTjdHX2JzWWdKMk1vSmczWER5XzVHM0VJX2dpVFBEUk1aYldlQkVwSlZCMHl5UUlUQU15U1ZObUtvLW5JNWVLN1VBZEZtNVB6NWZNQU9yVk5obnpPN3dsQlJMcmItaHFoM29pSVhaeFpSbEFyZjdwSUt2OTNlcHY1eXBxaHFxTFZqMjhfMkktUVhweFZpWktGWW9tclBmT0ZacFhKODlVcVMtd3VZQ09LSVFjM2FfcTlreWlHYjdac1p5czJQRC0zbzZ6Ty1aRW9MWEpHSzhBNlBvZks0d3BQbmV4WFE?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart","summary":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsight - Barchart","headline":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPSUE2WVp6NEdXRFVDRmdvSWFWaEN3bjNtY0tEX09lV2VTZUlTUGxvQWxuS0pydUlyQkY1cnpzMmhYblptazZOdGgtZzNxQWF2UThvM3pYQkhXSGxwekhzRWVlR25mcDAxM3VKdTdYVTFCRWl0Ym14ZkFxaXU1R0drRWhTRXVMb2R0Vy1wS2NtVXFUSXg3aHhxSEVNSnU0QkNrOE9pVkE3NEtsTTlMbHMtSTRfaWhZcFZSZnJRNXV1ejg?oc=5","date":"2026-01-20","type":"pipeline","source":"AFR","summary":"Wesfarmers attacks Priceline franchisee’s debt-fuelled expansion spree - AFR","headline":"Wesfarmers attacks Priceline franchisee’s debt-fuelled expansion spree","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxPN2ZBX3dJc3hiSXRmZ3g4dlhlWnUzN2ZpMGU2X05ZOTVYUVlUeWlRMGxPWGhVbEItSnVoamRjTjJuUDZXbDllUkZOVmRYNTA4SjZfUHA4SU9na1BGMHFXcFE1ZlZPQ3BwWUpPUGhNUWZ0WFgtVVVtYVRSWDI3djNZMWpwTk9XTU9SNFMzeGZSM3BETkJ5UWpBb1A5eDVyU1l4SmN4TEJtNTk3YnJOdlhrMkN1OXZWUXRRWDh0WEExLXBLcV9GWUpOVm02ejhmQjF5bHBldnlZUnVUQ0RuRER3VnRKdUZ1UDQxcVFSWUIxV2Z5RzloZFRnOW1VLWRTNVhjSUFJcUFNaWNRUWxEZEthdlcyZGpBVVlGRkNxckNvT0lkMm_SAagCQVVfeXFMUFM1WE96WFlYQ2FmVVNhdmxod1o1SmNYM0NkOTdiMktjYWV3b1FyVGlaR1h5N3FkMlpnVG5xQlhvWktSLXYyNF9IaTFxWGRKV2ctOElfT0E4NXIwcGFtaGhnekEtSnBjc2hfSjdFSTFWRE9CUTFESVM5UUxoamU3RXNqaEgyVkxBbnpyNzFqX1llQmNQdkNmdVNFVTVlQ0paZDRQN3Fvcm1QT2hIYU5iWHV0UW1OUmVwRjBqbVdLdnFKSTFjODE0bVFiNTYzdVpSSmlxenpCZUsyb2F1bGEtNkZZLXhiLVZDdFFoS3VqVWpHU0lhaWx6TjQweURhWGx3WGc3cFJBTmhPWS12cFhmVEtCYm1rVG5FODFNT0NiMDFUZ3pCUmVxbkI?oc=5","date":"2025-11-28","type":"pipeline","source":"The Times of India","summary":"Modi unveils Skyroot's Infinity campus, India's 1st pvt commercial rocket; says India set to be global le - The Times of India","headline":"Modi unveils Skyroot's Infinity campus, India's 1st pvt commercial rocket; says India set to be global le","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNcHJFbWk0bzJlSEdUMkt6ZnB6WkwzX3BUVWxlWUxQY0Z1aThFOW5rbEFtVXc1MWwyM0RtQ2lLbWdHNGlMOEJUYkhCbmhJcFZWQndKbHcwWllnbi0yVUppcUVXWG1EOGkwSzFGc3dEMGdnVTVka3V1ZS1IWHptRk01d0lFOXdhczlFUTY5a2FsYldpVWZscEE?oc=5","date":"2025-10-23","type":"trial","source":"Frontiers","summary":"Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial - Frontiers","headline":"Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5","date":"2025-08-12","type":"trial","source":"BioWorld News","summary":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M - BioWorld News","headline":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-09-12","type":"pipeline","source":"The Times of India","summary":"36 industries get plots in Medical Devices Park, to invest 1.8k crore - The Times of India","headline":"36 industries get plots in Medical Devices Park, to invest 1.8k crore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQbTJDQnprMGoxdkdtUWY0RXQ5TlRsME5vSTBldDlLWkNEZmhWb3NPVlF3aXRnQ25DOVJSTF9VbzNnMVRPN0lpd2tMODdDTzhzandlSmowempyWk1pbFRFUm1CT0txdV9RcmxBN1FBZHJ0Qzc1NjRxaUNSTTRPR2FfaENwUEVPNnZBQ0tIcERDd29tRUM3cE5BWExHbk4tbGJENEE?oc=5","date":"2024-08-08","type":"pipeline","source":"PharmaLive","summary":"Biopharma layoff tracker 2023: CSL Vifor, Infinity, Sana and more cut staff - PharmaLive","headline":"Biopharma layoff tracker 2023: CSL Vifor, Infinity, Sana and more cut staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYk9FM040ZGM4dnl3MEw4MlpQUENhYzRHMUdTMVFmUVk1eC1CMHBXdWowNm10TG1tM2lZWmxSUTBzQUJ4R1AzZ1htUW12TEoxNWhYQXBSdnFQVVNWUVZlRnE0VU9paW01QmRycmNTUS1yWDItSzVMNHZCaUVQQWkwcFpIeTl0cFJSZkpFTkdVQkVJWXRoRHFLRW9vYWI3Q0FhRTd0Z05YSzdjZw?oc=5","date":"2023-10-02","type":"deal","source":"The Business Journals","summary":"Gutted Cambridge biotech declares bankruptcy after failed merger, layoffs - The Business Journals","headline":"Gutted Cambridge biotech declares bankruptcy after failed merger, layoffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOS292RkV5aU5DdlEwUWZ4RFhCX0NydzhlV3FKVXR1OFJmTFJrZ1B0cUluM3hGenFTQXpBMGNZLTlDVTJReU1DQU1LNzNpZDM4eUJIa1BFM2JDay1jbzJ5V2Z2QTJHOUpneVBlVXdnSnpvWkZIV0phUllNak41SHZPYWZTS2twbTUwZE9QTV90QlgzZXJtOWxXUFhJcWlxQ0IyS21lX0ZMSll1a25nVHBQQi00VUVTbktaMEl5bWZ2QQ?oc=5","date":"2023-03-28","type":"pipeline","source":"Business Wire","summary":"Infinity Pharmaceuticals Reports Full Year 2022 Financial Results - Business Wire","headline":"Infinity Pharmaceuticals Reports Full Year 2022 Financial Results","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-02-22","type":"deal","source":"Indian Pharma Post","summary":"Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma - Indian Pharma Post","headline":"Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-10-20","type":"pipeline","source":"Medical Dialogues","summary":"42 drug samples fail to qualify CDSCO test, 1 declared misbranded - Medical Dialogues","headline":"42 drug samples fail to qualify CDSCO test, 1 declared misbranded","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNYXl5eXgxcU10Z2pVa2RHWVFvM09nOUZ5R2NRdVJvT0lWcEdtaUp2dTVKbU9sLXBBRV9hb1lCNkUzc09LRzJqOVRQMmY3ZWdNY2JwUk5sMG9NQXBUUkVNT20tVk9YRWg0bDk3T0pDTUpma1NpSG9nMDRtLUkteG5tV3JNS2ljN3hSdzdJd0pyS2ZoVWlJczRiZXkwZmxjNmhZMzM4MkVUdFRkUWFQT0lRMkdkdTFyTzJGdzU2Yi1Ick1IV05zR2g1U19WVl9GMnRuODNMTDJkYnc0VEF2Q1dv?oc=5","date":"2021-07-15","type":"pipeline","source":"McKinsey & Company","summary":"Roche’s Infinity model: Helping to transform the lives of patients with rare diseases - McKinsey & Company","headline":"Roche’s Infinity model: Helping to transform the lives of patients with rare diseases - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}